Pfizer in pact with China's Fosun Pharma for oral GLP-1 drugs
Source: SeekingAlpha
2025-12-09 10:10:06 ET
More on Pfizer, Shanghai Fosun Pharmaceutical
- Pfizer: The Market Is Still Wrong About It
- Pfizer: The Patent Cloud Is An Opportunity For Bargain Hunters
- Pfizer: Is This Pharma Giant Finally A Bargain
- Pfizer’s HYMPAVZI shows superior bleeding control in hemophilia phase 3 study
- Eli Lilly, Pfizer drugs added to China's state insurance list
Read the full article on Seeking Alpha
For further details see:
Pfizer in pact with China’s Fosun Pharma for oral GLP-1 drugs
Shanghai Fosun Pharmaceutical Co. Ltd.
NASDAQ: SFOSF
SFOSF Trading
-2.4% G/L:
$2.44 Last:
200 Volume:
$2.50 Open:
